1,472 results on '"Chen, Yi-Bin"'
Search Results
2. Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma
3. Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide
4. Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD
5. PTEN status determines therapeutic vulnerability to celastrol in cholangiocarcinoma
6. The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
7. Outcomes of a Formal Hematopoietic Cell Transplantation Survivorship Program on Screening for Late Effects
8. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD
9. Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract
10. A Day 14 Endpoint for Acute GVHD Clinical Trials
11. Protocol for multi-site randomized trial of inpatient palliative care for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation
12. Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD+ acute myeloid leukemia
13. Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies
14. Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year
15. Spatial transcriptomics reveals distinct tissue niches linked with steroid responsiveness in acute gastrointestinal GVHD
16. Splenic irradiation prior to allogeneic hematopoietic cell transplantation for patients with myelofibrosis
17. Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
18. Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
19. ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma
20. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD
21. A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
22. A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
23. Effective treatment of low-risk acute GVHD with itacitinib monotherapy
24. How I treat with maintenance therapy after allogeneic HCT
25. Delirium and Healthcare Utilization in Patients Undergoing Hematopoietic Stem Cell Transplantation
26. Trajectories of patient-reported outcomes after prolonged stays for hematopoietic cell transplant.
27. Chimeric antigen receptor T‐cell therapy in secondary central nervous system lymphoma: A multicenter analysis
28. CAR T Cells in Primary and Secondary CNS Lymphoma (S27.003)
29. Comparison of whole‐genome and immunoglobulin‐based circulating tumor DNA assays in diffuse large B‐cell lymphoma
30. Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignancies
31. Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)
32. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification
33. Emerging approaches to improve allogeneic hematopoietic cell transplantation outcomes for nonmalignant diseases
34. Fabrication of one-dimensional visible-light-driven BiOCl@WO3 p–n heterojunction with improved photocatalytic performance
35. Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial
36. GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial
37. JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia
38. Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial
39. Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosis.
40. Previously unreported WRAP53 gene variants in a patient with dyskeratosis congenita
41. A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease
42. Erythroid nuclear dysplasia is associated with inferior outcomes for patients with myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation
43. Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
44. Acute Myeloid Leukemia Presenting Less Than 3 Weeks After Living Donor Kidney Transplant: A Case Report
45. Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma
46. Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis
47. Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells
48. Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease
49. HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia
50. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.